Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

Yamanouchi prepares novel antimuscarinic agents for renal, GI and respiratory disorders

May 11, 1998

Wyeth-Ayerst has option to license Teikoku Hormone's antiandrogen

May 7, 1998

FDA clears CRYOcare surgical system to treat BPH

May 4, 1998

Cheung seeks FDA approval to begin testing of BPH treatment system

April 30, 1998

Takeda presents agents inhibiting PDGF activity for renal, cardiovascular disorders

April 29, 1998

New vasopressin V2 antagonists in development at Wakamoto

April 23, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Alza acquires Canadian rights to Ditropan

April 20, 1998

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.